Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2018-08-22 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 100% confidence The document is a formal notification regarding the exercise of share options by an Executive Vice President (Allan Rasmussen) of Coloplast A/S. It explicitly references the Market Abuse Regulation article 19, which governs the reporting of transactions by persons discharging managerial responsibilities (PDMRs). This falls directly under the definition of 'Director's Dealing' (DIRS).
2018-08-22 English
Report Publication Announcement 2018
Report Publication Announcement Classification · 99% confidence The document is explicitly titled 'Announcement no. 5/2018 - Interim Financial Report, 9M 2017/18' and contains key financial highlights and updated financial guidance for a nine-month period (9M 2017/18). This structure—providing key results and outlook for a period shorter than a full year—is characteristic of an Interim Report (IR). Although it contains 'Highlights' which might suggest an Earnings Release (ER), the depth of financial metrics (EBIT, ROIC, detailed segment growth) and the explicit mention of the 'Interim financial report' strongly point towards the comprehensive Interim Report (IR) category, rather than just the initial highlights (ER). The document length (3258 chars) is short, but it presents the core financial narrative, not just an announcement that a report is attached (which would be RPA/RNS). Therefore, it is classified as an Interim Report.
2018-08-08 English
Earnings Release 2018
Earnings Release Classification · 100% confidence The document is titled 'Selskabsmeddelelse nr. 5/2018 - Regnskabsmeddelelse, 9M 2017/18' and contains detailed financial highlights ('Hovedpunkter') for the first nine months (9M) of the fiscal year, including revenue growth, segment performance, operating profit (EBIT), and ROIC. It also provides updated financial guidance for the full year 2017/18. This structure—a summary of period results and forward guidance—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it covers nine months (9M), it is a comprehensive report for a period shorter than a year, fitting the definition of an Interim/Quarterly Report (IR). Although it is a 'Regnskabsmeddelelse' (Financial Announcement), the depth of the content suggests it is the report itself, not just a brief announcement of publication (RPA). The language is Danish, but the content maps directly to an IR. 9M 2018
2018-08-08 Danish
Announcement no. 5/2018 - Interim Financial Report, 9M 2017/18
Interim / Quarterly Report Classification · 100% confidence The document is a 'Regnskabsmeddelelse' (Financial Statement/Announcement) for Coloplast covering the 9-month period (9M 2017/18). It contains detailed financial tables (income statement, balance sheet, cash flow), management commentary on sales performance by business area and region, and updated financial guidance. It is a comprehensive interim report rather than a simple release or announcement of a report, as it provides substantive financial data and analysis for the specified period. 9M 2018
2018-08-08 Danish
Announcement no. 5/2018 - Interim Financial Report, 9M 2017/18
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive interim financial report for Coloplast for the 9-month period (1 October 2017 - 30 June 2018). It contains detailed financial statements, management's discussion and analysis (MDA), sales performance by business area and region, and financial highlights. It is not a mere announcement of a report (RPA) as it contains the full substantive financial data and analysis for the period. Therefore, it is classified as an Interim/Quarterly Report. 9M 2018
2018-08-08 English
Director's Dealing 2018
Director's Dealing Classification · 100% confidence The document explicitly details 'Trading in Coloplast shares by board members, executives or associated persons' and references the 'Market Abuse Regulation art. 19' regarding reporting transactions of executives and related parties. It lists a specific transaction (Purchase of shares) by a board member, including trade date, price, and market value. This content directly matches the definition of Director's Dealing (insider trades by executives/directors). The corresponding code is DIRS.
2018-06-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.